Nuvation Bio Inc. Class A Common Stock vs Truist Financial Corporation Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Truist Financial Corporation Common Stock trades at $46.1 (market cap $55.68B). The key difference: Truist Financial Corporation Common Stock is far larger — about 32.6× Nuvation Bio Inc. Class A Common Stock's market cap, and Truist Financial Corporation Common Stock pays a 4.56% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Truist Financial Corporation Common Stock for 0 Days on average.
| NUVB | TFC | |
|---|---|---|
Market Cap | $1.71B | $55.68B |
Volume | 5,448,712 | 7,292,374 |
Sector | Health | Financials |
52-Week High | $9.54 | $55.81 |
52-Week Low | $3.41 | $41.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $121.94B |
Dividend Yield | — | 4.56% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Truist Financial provides consumer and commercial banking, wealth management, insurance, and investment services in the United States.
Read more on TFC →